Atlas Trials

Feasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma Survivors

Clinical trial NCT06480526 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06480526
Sponsor
St. Jude Children's Research Hospital
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
High-risk Neuroblastoma
Start date
2024-10-21
Primary completion
2026-12-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.